NLS PHARMACEUTICS LTD (NLSP)

CH0523961370 - Common Stock

4.39  +0.79 (+21.94%)

After market: 3.92 -0.47 (-10.71%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2017 2018 2019 2020 2021 2022 2023 2024 2025
Revenue
YoY % growth
N/A
EBITDA
YoY % growth
N/A-11.85M-15.47M
-30.55%		-11.796M
23.75%		N/A
EBIT
YoY % growth
-2.3M
45.24%		-11.86M
-415.65%		-15.48M
-30.52%		-11.807M
23.73%		N/A
81.91%
Operating Margin
N/AN/AN/AN/AN/A
EPS
YoY % growth
N/AN/A
-5.88%		N/A
-1.24%		N/A
30.49%		N/A
89.47%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A -3900% -255.56%
RevenueN/A N/A N/A N/A